BCTX

Briacell Therapeutics Corp

NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY

$4.21

-0.24% today

Updated 2026-09-18

Market cap

$31.58M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.85

Dividend yield

—

52W range

$3 – $15

Volume

0.3M

Market cap

$31.58M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.85

Dividend yield

—

52W range

$3 – $15

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →253 stocks currently score above 75

Price targets

Analyst target

$150.00

+3462.95%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-7.21M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	—	$0.00
Net income	$-34.42M	$-27.11M	$-4.79M	$-36.49M	$-7.16M
EPS	—	—	—	—	$-0.85
Free cash flow	$-15.87M	$-31.89M	$-33.59M	$-39.07M	$-7.21M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BCTX	$31.58M	23	4.3	3.0	5.0	6.0	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-77.20%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	5.5	-15.43%	Buy

Smart narrative

Briacell Therapeutics Corp trades at $4.21. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Briacell Therapeutics Corp's stock price?

Briacell Therapeutics Corp (BCTX) trades at $4.21.

Is Briacell Therapeutics Corp overvalued?

Briacell Therapeutics Corp carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Briacell Therapeutics Corp (BCTX)?

The 12-month analyst consensus target is $150.00, about 3462.9% above the current $4.21. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-124.86%

Beta1.53

50D MA$3.61

200D MA$4.75

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BCTX vs LLY →BCTX vs JNJ →BCTX vs ABBV →Stock screener →